Peritoneal macrophage priming in cirrhosis is related to ERK phosphorylation and IL-6 secretion
Correction(s) for this article
-
Corrigendum
- Volume 41Issue 4European Journal of Clinical Investigation
- pages: 464-464
- First Published online: March 9, 2011
Antonio J. Ruiz-Alcaraz
Department of Biochemistry and Molecular Biology B and Immunology, School of Medicine, Universidad de Murcia, Murcia, Spain
Search for more papers by this authorMaría Martínez-Esparza
Department of Biochemistry and Molecular Biology B and Immunology, School of Medicine, Universidad de Murcia, Murcia, Spain
Search for more papers by this authorRocío Caño
Unidad Hepática, Hospital General Universitario, Alicante, Spain
Search for more papers by this authorTrinidad Hernández-Caselles
Department of Biochemistry and Molecular Biology B and Immunology, School of Medicine, Universidad de Murcia, Murcia, Spain
Search for more papers by this authorChiara Recarti
Department of Biochemistry and Molecular Biology B and Immunology, School of Medicine, Universidad de Murcia, Murcia, Spain
Search for more papers by this authorLucía Llanos
Unidad Hepática, Hospital General Universitario, Alicante, Spain
Search for more papers by this authorPedro Zapater
Unidad Hepática, Hospital General Universitario, Alicante, Spain
CIBERehd, Instituto de Salud Carlos III, Madrid, Spain
Search for more papers by this authorAna Tapia
Department of Biochemistry and Molecular Biology B and Immunology, School of Medicine, Universidad de Murcia, Murcia, Spain
Search for more papers by this authorElena Martín-Orozco
Department of Biochemistry and Molecular Biology B and Immunology, School of Medicine, Universidad de Murcia, Murcia, Spain
Search for more papers by this authorMiguel Pérez-Mateo
Unidad Hepática, Hospital General Universitario, Alicante, Spain
Search for more papers by this authorJosé Such
Unidad Hepática, Hospital General Universitario, Alicante, Spain
CIBERehd, Instituto de Salud Carlos III, Madrid, Spain
Search for more papers by this authorPilar García-Peñarrubia
Department of Biochemistry and Molecular Biology B and Immunology, School of Medicine, Universidad de Murcia, Murcia, Spain
Search for more papers by this authorRubén Francés
Unidad Hepática, Hospital General Universitario, Alicante, Spain
CIBERehd, Instituto de Salud Carlos III, Madrid, Spain
Search for more papers by this authorAntonio J. Ruiz-Alcaraz
Department of Biochemistry and Molecular Biology B and Immunology, School of Medicine, Universidad de Murcia, Murcia, Spain
Search for more papers by this authorMaría Martínez-Esparza
Department of Biochemistry and Molecular Biology B and Immunology, School of Medicine, Universidad de Murcia, Murcia, Spain
Search for more papers by this authorRocío Caño
Unidad Hepática, Hospital General Universitario, Alicante, Spain
Search for more papers by this authorTrinidad Hernández-Caselles
Department of Biochemistry and Molecular Biology B and Immunology, School of Medicine, Universidad de Murcia, Murcia, Spain
Search for more papers by this authorChiara Recarti
Department of Biochemistry and Molecular Biology B and Immunology, School of Medicine, Universidad de Murcia, Murcia, Spain
Search for more papers by this authorLucía Llanos
Unidad Hepática, Hospital General Universitario, Alicante, Spain
Search for more papers by this authorPedro Zapater
Unidad Hepática, Hospital General Universitario, Alicante, Spain
CIBERehd, Instituto de Salud Carlos III, Madrid, Spain
Search for more papers by this authorAna Tapia
Department of Biochemistry and Molecular Biology B and Immunology, School of Medicine, Universidad de Murcia, Murcia, Spain
Search for more papers by this authorElena Martín-Orozco
Department of Biochemistry and Molecular Biology B and Immunology, School of Medicine, Universidad de Murcia, Murcia, Spain
Search for more papers by this authorMiguel Pérez-Mateo
Unidad Hepática, Hospital General Universitario, Alicante, Spain
Search for more papers by this authorJosé Such
Unidad Hepática, Hospital General Universitario, Alicante, Spain
CIBERehd, Instituto de Salud Carlos III, Madrid, Spain
Search for more papers by this authorPilar García-Peñarrubia
Department of Biochemistry and Molecular Biology B and Immunology, School of Medicine, Universidad de Murcia, Murcia, Spain
Search for more papers by this authorRubén Francés
Unidad Hepática, Hospital General Universitario, Alicante, Spain
CIBERehd, Instituto de Salud Carlos III, Madrid, Spain
Search for more papers by this authorAbstract
Eur J Clin Invest 2010; 41 (1): 8–15
Background Bacterial infections are common complications arising in patients with cirrhosis and ascites. Translocation of bacterial DNA is a dynamic process that is associated with an increased inflammatory response and a poor prognosis in this setting. The aim of this study was to study whether peritoneal macrophages remain in a chronic primed status to allow a rapid response to subsequent events of bacterial translocation.
Patients and methods Peritoneal monocyte-derived macrophages were isolated from 25 patients with cirrhosis and non-infected ascites and compared with donor’s blood monocytes. Activation cell-surface markers were screened using flow-cytometry, and the phosphorylation state of ERK 1/2, p38 MAP Kinase, PKB/Akt and transcription factors c-Jun and p65 NFκB were evaluated using Western blot. Synthesis of tumour necrosis factor alpha, interleukin 6 (IL-6) and interleukin-10 (IL-10) at baseline and in response to bacterial stimuli was evaluated using ELISA.
Results A high expression of CD54, CD86 and HLA-DR at baseline was displayed by peritoneal macrophages. Increased phosphorylated levels of ERK1/2, protein kinase B (PKB) and c-Jun, together with IL-6 production, were observed in peritoneal macrophages at baseline compared with donors’ blood monocytes. A positive correlation was established between basal IL-6 levels and extracellular signal-regulated kinase (ERK) phosphorylation in peritoneal macrophages from patients with cirrhosis (r = 0·9; P = 0·005). Addition of lipopolysaccharide induced higher phosphorylation levels of all studied signalling intermediates than synthetic-oligodeoxydinucleotides, but similar end-stage p65 NFκB.
Conclusions A sustained immune response is present in ascitic fluid of cirrhotic patients, even in the temporal absence of bacterial antigens. This would facilitate a fast response, probably controlled by IL-6, against repeated bacterial-DNA translocation or in liver chronic inflammation.
References
- 1 Such J, Runyon BA. Spontaneous bacterial peritonitis. Clin Infect Dis 1998; 27: 669–74.
- 2 Berg RD. Bacterial translocation from the gastrointestinal tract. J Med 1992; 23: 217–44.
- 3 Runyon BA. Patients with deficient ascitic fluid opsonic activity are predisposed to spontaneous bacterial peritonitis. Hepatology 1988; 8: 632–5.
- 4 Such J, Guarner C, Enriquez J, Rodriguez JL, Seres I, Vilardell F. Low C3 in cirrhotic ascites predisposes to spontaneous bacterial peritonitis. J Hepatol 1988; 6: 80–4.
- 5 Turchyn LR, Baginski TJ, Renkiewicz RR, Lesch CA, Mobley JL. Phenotypic and functional analysis of murine resident and induced peritoneal macrophages. Comp. Med. 2007; 57: 574–80.
- 6 Heller J, Sogni P, Barriére E, Tazi KA, Chauvelot-Moachon L, Guimont MC et al. Effects of lipopolysaccharide on TNF-alpha production, hepatic NOS2 activity, and hepatic toxicity in rats with cirrhosis. J Hepatol 2000; 33: 376–81.
- 7 Riordan SM, Williams R. The intestinal flora and bacterial infections in cirrhosis. J Hepatol 2006; 45: 744–57.
- 8 Frances R, Zapater P, Gonzalez-Navajas JM, Muñoz C, Caño R, Moreu R et al. Bacterial DNA in patients with cirrhosis and noninfected ascites mimics the soluble immune response established in patients with spontaneous bacterial peritonitis. Hepatology 2008; 47: 978–85.
- 9 Frances R, Muñoz C, Zapater P, Uceda F, Gascón I, Pascual S et al. Bacterial DNA activates cell mediated immune response and nitric oxide overproduction in peritoneal macrophages from patients with cirrhosis and ascites. Gut 2004; 53: 860–4.
- 10 Such J, Hillebrand DJ, Guarner C, Berk L, Zapater P, Westengard J et al. Nitric oxide in ascitic fluid is an independent predictor of the development of renal impairment in patients with cirrhosis and spontaneous bacterial peritonitis. Eur J Gastroenterol Hepatol 2004; 16: 571–7.
- 11 Garcia-TSAO G, Angulo P, Garcia JC, Groszmann RJ, Cadelina GW. The diagnostic and predictive value of ascites nitric oxide levels in patients with spontaneous bacterial peritonitis. Hepatology 1998; 28: 17–21.
- 12 Such J, Hillebrand DJ, Guarner C, Berk L, Zapater P, Westengard J et al. Tumor necrosis factor alpha, interleukin-6 and nitric oxide in sterile ascitic fluid and serum from patients with cirrhosis who subsequently develop ascitic fluid infection. Dig Dis Sci 2001; 46: 2360–6.
- 13 Byl B, Roucloux I, Crusiaux A, Dupont E, Deviere J. Tumor necrosis factor alpha and interleukin 6 plasma levels in infected cirrhotic patients. Gastroenterology 1993; 104: 1492–7.
- 14 Albillos A, Cuervas Mons V, Millan I, Cantón T, Montes J, Barrios C et al. Ascitic fluid polymorphonuclear cell count and serum to ascites albumin gradient in the diagnosis of bacterial peritonitis. Gastroenterology 1990; 98: 134–40.
- 15 Rangel-Frausto MS, Pittet D, Costigan M, Hwang T, Davis CS, Wenzel RP. The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. JAMA 1995; 273: 117–23.
- 16 Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N. Engl. J. Med. 1996; 334: 693–9.
- 17 Runyon BA. Paracentesis of ascitic fluid: a safe procedure. Arch Intern Med 1986; 146: 2259–61.
- 18 Runyon BA, Canawati HN, Akriviadis EA. Optimization of ascitic fluid culture technique. Gastroenterology 1988; 95: 1351–5.
- 19 Albillos A, Hera Ad AL, Reyes E, Monserrat J, Muñoz L, Nieto M et al. Tumour necrosis factor-alpha expression by activated monocytes and altered T-cell homeostasis in ascitic alcoholic cirrhosis: amelioration with norfloxacin. J. Hepatol. 2004; 40: 624–31.
- 20 Zapater P, Cano R, Llanos L, Ruiz-Alcaraz AJ, Pascual S, Barquero C et al. Norfloxacin modulates the inflammatory response and directly affects neutrophils in patients with decompensated cirrhosis. Gastroenterology 2009; 137: 1669–79.
- 21 Simera I, Moher D, Hoey J, Schulz KF, Altman DG. A catalogue of reporting guidelines for health research. Eur J Clin Invest 2010; 40: 35–53.
- 22 Such J, Frances R, Munoz C, Zapater P, Casellas JA, Cifuentes A et al. Detection and identification of bacterial DNA in patients with cirrhosis and culture-negative, nonneutrocytic ascites. Hepatology 2002; 36: 135–41.
- 23 Frances R, Benlloch S, Zapater P, González JM, Lozano B, Muñoz C et al. A sequential study of serum bacterial DNA in patients with advanced cirrhosis and ascites. Hepatology 2004; 39: 484–91.
- 24 Zapater P, Frances R, Gonzalez-Navajas JM, De La Hoz MA, Moreu R, Pascual S et al. Serum and ascitic fluid bacterial DNA: a new independent prognostic factor in noninfected patients with cirrhosis. Hepatology 2008; 48: 1924–31.
- 25 Jones SA. Directing transition from innate to acquired immunity: defining a role for IL-6. J. Immunol. 2005; 175: 3463–8.
- 26 Kishimoto T, Akira S, Narazaki M, Taga T. Interleukin-6 family of cytokines and gp130. Blood 1995; 86: 1243–54.
- 27 Barton BE, Jackson JV. Protective role of interleukin 6 in the lipopolysaccharide-galactosamine septic shock model. Infect Immun 1993; 61: 1496–9.
- 28 Diao H, Kohanawa M. Endogenous interleukin-6 plays a crucial protective role in streptococcal toxic shock syndrome via suppression of tumor necrosis factor alpha production. Infect. Immun. 2005; 73: 3745–8.
- 29 Wendling D, Racadot E, Wijdenes J. Treatment of severe rheumatoid arthritis by anti-interleukin 6 monoclonal antibody. J Rheumatol 1993; 20: 259–62.
- 30 Ito H, Takazoe M, Fukuda Y, Hibi T, Kusugami K, Andoh A et al. A pilot randomized trial of a human anti-interleukin-6 receptor monoclonal antibody in active Crohn’s disease. Gastroenterology 2004; 126: 989–96.
- 31 Louis H, Van Laethem JL, Wu W, Quertinmont E, Degraef C, Van den Berg K et al. Interleukin-10 controls neutrophilic infiltration, hepatocyte proliferation, and liver fibrosis induced by carbon tetrachloride in mice. Hepatology 1998; 28: 1607–15.
- 32 Arrieta MC, Madsen K, Doyle J, Meddings J. Reducing small intestinal permeability attenuates colitis in the IL10 gene-deficient mouse. Gut 2009; 58: 41–8.
- 33 Roberts TL, Dunn JA, Terry TD, Jennings MP, Hume DA, Sweet MJ et al. Differences in macrophage activation by bacterial DNA and CpG-containing oligonucleotides. J Immunol 2005; 175: 3569–76.
- 34 Dowling D, Hamilton CM, O’Neill SM. A comparative analysis of cytokine responses, cell surface marker expression and MAPKs in DCs matured with LPS compared with a panel of TLR ligands. Cytokine 2008; 41: 254–62.
- 35 Daigneault M, Preston JA, Marriott HM, Whyte MK, Dockrell DH. The Identification of markers of macrophage differentiation in PMA-stimulated THP-1 cells and monocyte-derived macrophages. PLoS ONE 2010; 5: e8668.
- 36 Tudhope SJ, Finney-Hayward TK, Nicholson AG, Mayer RJ, Barnette MS, Barnes PJ et al. Different mitogen-activated protein kinase-dependent cytokine responses in cells of the monocyte lineage. J Pharmacol Exp Ther 2008; 324: 306–12.